Skip Navigation



Rheumatology Advance Access published online on April 21, 2006
Rheumatology, doi:10.1093/rheumatology/kel071
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/11/1422    most recent
kel071v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sutaria, S.
Right arrow Articles by Underwood, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutaria, S.
Right arrow Articles by Underwood, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received October 16, 2005
Accepted February 7, 2006

Concise Report

Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review

S. Sutaria 1 *, R. Katbamna 1, and M. Underwood 1

1 Barts and The London, Queen Mary, University of London, Institute of Health Sciences, London, UK

* To whom correspondence should be addressed.
S. Sutaria, E-mail: shailen000{at}yahoo.co.uk


  Abstract

Objective. To determine the evidence for the effectiveness of treatments for acute gout and the prevention of recurrent gout.

Method. Seven electronic databases were searched for randomized controlled trials of treatments for gout from their inception to the end of 2004. No language restrictions were applied. All randomized controlled trials of treatments routinely available for the treatment of gout were included. Trials of the prevention of recurrence were included only if patients who had had gout and had at least 6 months of follow-up were studied.

Results. We found 13 randomized controlled trials of treatment for acute gout, two of which were placebo controlled. Colchicine was found to be effective in one study; however, the entire colchicine group developed toxicity. The only robust conclusion from studies of non-steroidal anti-inflammatory drugs is that pain relief from indometacin and etoricoxib are equivalent. We found one randomized controlled trial, reported only as a conference abstract, of recurrent gout prevention.

Conclusion. The shortage of robust data to inform the management of a common problem such as gout is surprising. All of the drugs used to treat gout can have serious side effects. The incidence of gout is highest in the elderly population. It is in this group, who are at a high risk of serious adverse events, that we are using drugs of known toxicity. The balance of risks and benefits for the drug treatment of gout needs to be reassessed.

Keywords: Gout; Treatment; Systematic review.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.